首页 >
法规速递
-
Document: 3-year rolling work plan for the Quality Innovation Group (QIG) 2026-2028-2026/1/15
2026-01-16查看详情 > -
Page: Medicine evaluation figures-2026/1/15
2026-01-16查看详情 > -
Page: Clinical investigation of medicinal products in the treatment of peripheral-arterial occlusive disease - Scientific guideline-2026/1/15
2026-01-16查看详情 > -
Page: Classification of changes: questions and answers-2026/1/15
2026-01-16查看详情 > -
Document: European Medicines Agency post-authorisation procedural advice for users of the centralised procedure-2026/1/15
2026-01-16查看详情 > -
Document: European Medicines Agency post-authorisation procedural advice for users of the centralised procedure: document with tracked changes-2026/1/15
2026-01-16查看详情 > -
Document: Guiding principles of good AI practice in drug development-2026/1/14
2026-01-15查看详情 > -
Page: International Coalition of Medicines Regulatory Authorities (ICMRA)-2026/1/14
2026-01-15查看详情 > -
Document: List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment-2026/1/14
2026-01-15查看详情 > -
Document: Dates of 2026 Scientific Advice Working Party - Human (SAWP-H) meetings and submission deadlines for scientific advice, protocol assistance, qualification of novel methodologies and HTACG/EMA parallel Joint Scientific Consultation (JSC) requests
2026-01-14查看详情 >
